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Abstract
Aims: The aims were to investigate whether baseline characteristics and problematic substance use
were related to change in mental distress over time in patients with substance use disorders during
an 18-year period. Method: This was a prospective, longitudinal study of patients followed for 18
years after entering specialised treatment for substance use disorders. A sample of 291 patients
was recruited in 1997 and 1998. Mental distress was measured using the Hopkins Symptom
Checklist 25 at baseline, and at six and 18 years. Lifetime psychiatric disorders and substance use
disorders at baseline were measured using the Composite International Diagnostic Interview,
while personality disorders were measured using the Millon Clinical Multiaxial Inventory II. At the
six- and 18-year follow-ups, substance use was measured using the Alcohol Use Disorders Iden-
tification Test and the Drug Use Disorders Identification Test. Linear mixed model was estimated
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to assess the overall level of mental distress over 18 years for participants with complete data at
baseline (n ¼ 232). Results: In an adjusted model, problematic substance use assessed simulta-
neously with mental distress, having lifetime affective, anxiety and personality disorder at baseline
were associated with greater levels of mental distress over the 18-year period. The change in
mental distress from baseline to the six-year, but not to the 18-year, follow-up was significantly
larger among females than among males. Conclusion: The results suggests a reciprocal rela-
tionship over time between substance use and mental health problems. Also, there seems to be an
additive effect between ongoing problematic substance use and lifetime mental disorders on
greater levels of mental distress. This addresses the importance of integrated treatment for both
substance use disorders and mental disorders to improve the long-term course for patients with
these comorbid disorders.
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Epidemiological studies have documented sub-
stantial comorbidity of substance use disorders
(SUDs) and other mental disorders (Lai et al.,
2015; Regier et al., 1990). This comorbidity is
higher in clinical than general populations
(Andreas et al., 2015; Landheim et al., 2002), and
patients with SUDs have higher psychiatric
comorbidity than patients with psychiatric disor-
ders have comorbidity with SUDs (Morisano
et al., 2014). Patients with severe SUDs, as in
poly-substance use, also have more mental health
problems than do those with less severe SUDs
(McCabe & West, 2017), and patients tend to
have poorer outcomes if a mental disorder occurs
before SUDs (Najt et al., 2011). In addition,
females in treatment for SUDs have higher psy-
chiatric comorbidity than males, particularly in
terms of mood and anxiety disorders (Brady &
Randall, 1999; Landheim et al., 2003; Zilberman
et al., 2003).
In general, there are few longitudinal studies
of clinical cohorts of patients with SUDs. Long-
itudinal studies typically examine the course of
substance use and risk factors for substance use
relapse (Heyman, 2013; Hser et al., 2015; Moos
& Moos, 2006) or mortality (Degenhardt et al.,
2011; Giraudon et al., 2015; Roerecke & Rehm,
2013). Mental disorders are among the most
studied and documented risk factors for poor
long-term outcomes in patients with SUDs
(Bradizza et al., 2006; Landheim et al., 2006).
However, studies rarely focus on the long-term
course of mental health and the prospective
relationship between substance use and mental
health over time in patients with a history of
SUDs (Andreas et al., 2015). Repeated-
measurements analysis has shown an associa-
tion over time between increased psychiatric
symptom load and increased substance use dur-
ing a nine-year observation period in persons
seeking treatment for SUDs in the US (Chi
& Weisner, 2008). In another repeated-
measurements analysis of a Norwegian cohort
of patients with SUDs, both the levels and devel-
opment of mental distress over time were related
to the number of substances used during a 10-
year observation period (Andreas et al., 2015).
We have previously found that six years after
entering treatment for SUDs, mental distress
was stable relative to baseline in patients with
active problematic substance use (Bakken et al.,
2007). By contrast, those with no current proble-
matic substance use, and especially females,
reported a significant decrease in mental distress
compared with baseline. In that study, we also
found that lifetime mental disorders, personality
disorders, and substance use factors measured at
baseline were predictors for having greater lev-
els of mental distress at the six-year follow-up
(Bakken et al., 2007).
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The associations between SUDs and mental
health problems and development over time are
complex and are not fully understood (Swendsen
et al., 2010). Several explanations have been
offered, but no single explanation accounts for all
of the variance (Morisano et al., 2014). We know
that this comorbidity reduces quality of life (Col-
paert et al., 2012), and can lead to poor treatment
adherence (Weiss et al., 2002) and treatment out-
come (Bahorik et al., 2013), including more fre-
quent substance use relapse and hospitalisation
(Morisano et al., 2014). Understanding the reci-
procal relationship between mental health prob-
lems and substance use over time in different
SUD sub-groups and stages is important for the
development of effective tailored treatment and
relapse-prevention programmes.
The present material is from a longitudinal 18-
year follow-up study of a heterogeneous cohort of
patients who sought treatment for SUDs. The
patients had long-lasting and severe SUDs with
a high comorbidity for lifetime mental disorders.
The aims were to investigate whether sex, age,
psychiatric diagnosis, or substance use factors at
baseline and problematic substance use at follow-
ups assessed longitudinally were related to
change in mental distress over time in patients
with SUDs during an 18-year period.
Material and method
Design
This was a longitudinal cohort study with three
measuring points over a period of 18 years.
Patients entering specialised treatment for SUDs
in public facilities in two Norwegian counties in
1997 and 1998 were invited to participate in the
study (T0). Follow-up measurements were con-
ducted by mailed questionnaires to living partici-
pants about six years (T1), and 18 years later (T2).
Sample
At T0, 291 patients (mean age 38.3 years, stan-
dard deviation [SD] ¼ 11.4 years; 72% male)
from three outpatient (42%) and six inpatient
(58%) units were recruited. The mean time since
the first onset of SUD at T0 was 13.8 years (SD¼
8.8 years), and 46% had experienced onset of a
SUD before the age of 18 years. The prevalence
of lifetime psychiatric symptom disorders other
than SUDs at T0 was 91%; 83% had a lifetime
anxiety disorder, 65% had a lifetime affective
disorder, and 63% had three or more lifetime
psychiatric disorders. Among the recruited
patients, 291 (100%) had one or several SUDs
both in their lifetime and during the past 12
months; 130 (45%) had lifetime alcohol use dis-
order (AUD) alone, and 161 (55%) had poly-
SUDs. This latter group had an average of 3.6
(SD ¼ 2.0) lifetime SUDs (the term “poly-
SUDs” is not entirely accurate, as 18 patients
[11%] had only one lifetime SUD other than
AUD: six had only opiate, six had only cannabis,
four had only sedative, and two had only stimu-
lant use disorder). Among the patients with poly-
SUDs, 53% had lifetime opioid dependence,
49% lifetime stimulant dependence, 50% life-
time sedative, hypnotic, or anxiolytic depen-
dence, 41% lifetime cannabis dependence, and
65% lifetime alcohol dependence. Patients with
AUD alone more often tended to be males (77%
vs 67%, p ¼ .055), to be older (45.8 vs 32.1
years, p < .001), to have fewer lifetime psychia-
tric disorders (3.2 vs 3.9, p¼ .027), and to be less
likely to have lifetime affective disorders (57%
vs 69%, p ¼ .047), lifetime anxiety disorders
(76% vs 88%, p¼ .010), and current personality
disorders (63% vs 80%, p ¼ .003) at T0 com-
pared with patients with poly-SUDs.
At T1, 33 (11%) patients had died, 160 par-
ticipated, and 98 did not (14 declined, 23 could
not be located, and 61 did not respond). At T2,
96 (33%) patients had died, 91 participated and
104 did not (22 declined, 14 could not be
located, and 68 did not respond). Participants
who responded at T2 received 400 Norwegian
kroner (*43 euro).
Measurements
T0.. The Composite International Diagnostic
Interview (CIDI), Norwegian computer version,
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a structured personal psychiatric interview
based on Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition criteria, and the
corresponding lifetime non-hierarchical diag-
noses in the International Classification of Dis-
eases, 10th Edition (ICD-10) (Robins et al.,
1988) were used. Lifetime ICD-10 diagnoses
from F30 to F34 were clustered into “Affective
disorder lifetime T0”, and all lifetime ICD-10
diagnoses from F40 to F44 were clustered into
“Anxiety disorder lifetime T0”. SUDs, depen-
dence or abuse, were measured with the CIDI
both as lifetime diagnoses and during the previ-
ous 12 months at T0. The Millon Clinical Multi-
axial Inventory II (MCMI-II), a self-report
psychiatric diagnostic (Diagnostic and Statisti-
cal Manual of Mental Disorders, 3rd Edition,
Revised) inventory (Choca et al., 1992) was used
on personality disorders, where diagnoses were
given using a cut-off base-rate score of 85 or
higher. The Hopkins Symptom Checklist-25
(HSCL-25), a self-report instrument composed
of 25 items on a four-point scale was used to
measure mental distress during the past week
(Derogatis et al., 1974; Strand et al., 2003). The
mean of all items on the HSCL-25 is called the
Global Severity Index (GSI).
T1. The HSCL-25 was repeated. The Alcohol
Use Disorders Identification Test (AUDIT)
(Saunders et al., 1993) and the Drug Use Dis-
orders Identification Test (DUDIT) (Berman
et al., 2004), both self-report screening instru-
ments for identifying problematic use of sub-
stances during the past 12 months were also
used. The AUDIT is composed of 10 items;
cut-off scores of 8 or more for males and 6 or
more for females were used. The DUDIT has 11
items; cut-off scores of 6 or more for males and
2 or more for females were used.
T2. The HSCL-25, the AUDIT and the DUDIT
were repeated. National identity numbers for all
patients (n ¼ 291) were merged with data from
the Norwegian Cause of Death Registry, pro-
viding dates of death until 31 June 2016.
Definition of problematic substance use
All participants had one or several SUDs during
the past 12 months at T0 measured with the CIDI,
and were defined as having “problematic sub-
stance use” at T0. Participants at T1 and at T2
were divided into those with “no problematic
substance use” (AUDIT < cut-off and DUDIT
< cut-off during the past 12 months at T1 or T2
accordingly) and participants with “problematic
substance use” (AUDIT  cut-off and/or
DUDIT  cut-off during the past 12 months at
T1 or T2 accordingly).
Loss of participants and missing data
Figure 1 shows a flow diagram illustrating par-
ticipation and loss of participants during the 18
years of observation, as well as the foundation
for the data analysis. Except for the loss of par-
ticipants to death and non-participation, there
were few missing data. The exceptions were at
T0, the HSCL-25 was not answered by 37 (13%)
participants and the MCMI-II was not answered
by 27 (9%) participants. Four participants (1%)
did not complete all sections on affective disor-
ders, and eight (3%) participants did not com-
plete all sections on anxiety disorders in the
CIDI at T0. Missing single values at T1 and T2
on the HSCL-25, AUDIT and DUDIT were
handled by calculating the mean of the remain-
ing items if missing items comprised < 20%
(only one HSCL-25 score at T1 was excluded
because of missing values). Among the 291
recruited participants, 232 (80%) participants
had complete data, that is, no missing values
on all assessed covariates, at T0.
Statistical Analysis
Data are presented by appropriate descriptive
statistics. We compared participants with com-
plete data on all assessed covariates at T0 (n ¼
232) with those excluded because of one or more
missing values at T0 (n ¼ 59), and among those
with complete data at T0 living (n ¼ 158) with
deceased (n ¼ 74) participants at T2 by
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independent samples t-test for continuous andw2
test for categorical variables. A linear mixed
model (LMM) was estimated to assess differ-
ences in levels of the HSCL-25 GSI from T0 to
T1, and T0 to T2 among participants with com-
plete data at T0 (n ¼ 232). Fixed effects at each
time point were included, with T0 as the refer-
ence. Random intercepts for participants were
included to account for within-participant corre-
lations due to repeated measurements. An auto-
regressive covariance structure was employed.
Unadjusted models with main effects for time
and each pre-defined covariate (sex, age, proble-
matic substance use at T0, T1 and T2, lifetime
affective disorder at T0, lifetime anxiety disor-
der at T0, personality disorder at T0, first onset of
SUD before 18 years of age, and having only
AUD at T0) and interactions between time and
each covariate were estimated first. Interaction
between time and problematic substance use
could not be estimated because zero participants
had “no problematic substance use” at T0 and
were therefore not included. Next, an adjusted
model containing time, all covariates and inter-
actions between time and each covariate was
estimated and reduced by applying Akaike’s
Information Criterion (AIC), where the smaller
value means better model. Age and sex were
kept in the adjusted model regardless of the
value of AIC. The results were presented as
regression coefficients and standard errors (SE).
The LMM assumes a non-informative cen-
soring, i.e., that death and outcome of interest
are not associated. Due to the high number of
deaths in the given data set, it is not unlikely that
death cannot be treated as non-informative, in
Figure 1. Flow diagram of the participants, data collection and analysed data.
*Participants with complete data, that is, no missing values on all assessed covariates, at T0.
**Among the 96 deceased participants at T2, 74 participants had complete data at T0.
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which case the LMM might produce biased esti-
mates of regression coefficients and SEs. To
assess this issue in detail, the joint model with
longitudinal process modelled by the LMM and
survival process modelled by Weibul propor-
tional hazards survival model was estimated.
Unadjusted and adjusted joint models did not
show any statistically significant association
between the two types of outcomes (longitudinal
and survival). Moreover, SEs of coefficients as
well as variances of random effects were similar
to those obtained from the LMM. Hence, death
could be treated as non-informative and only the
results of the LMM were presented.
All analyses were employed using SPSS for
Windows (version 25.0; IBM SPSS, Armonk,
NY), SAS version 9.4, STATA version 16 and
R version 3.6.0 (ISNI package version 1.1).
Results
As shown in Table 1, the baseline characteristics
did not differ significantly between participants
with complete data at T0 (n ¼ 232) and those
excluded from further analysis because of miss-
ing values at T0 (n¼ 59). Among the participants
with complete data at T0, 74 had died at T2. The
participants who died during the observation
period were older, had more seldom experienced
onset of first SUD before 18 years of age, were
more likely to have only AUD compared with
poly-SUDs, and had less lifetime affective dis-
orders measured at T0 compared with partici-
pants still living at T2 (n ¼ 158).
Table 2 shows the levels of mental distress as
measured by the GSI in all participants with
complete data at T0 (n ¼ 232) and in different
sub-groups at each time point. Participants with
lifetime affective or anxiety disorder, or current
personality disorder at T0, had a higher GSI than
did those without these disorders at each time
point. In addition, participants with ongoing pro-
blematic substance use had a higher GSI than did
those with no current problematic substance use
at both T1 and T2.
Table 3 presents the results of the LMM
assessing covariates associated to changes in the
GSI over time. Unadjusted for other covariates,
there was no significant change in GSI from T0
to T1 (p ¼ .215), while a significant decrease in
GSI was found from T0 to T2 (p ¼ .049). In the
adjusted model, the only interaction identified
was between time and sex, implying that the
change in GSI from T0 to T1 was significantly
different between males and females (p¼ .044).
Also, females had significantly higher GSI at T0
than males (p ¼ .019). The interaction is also
illustrated in Figure 2. Moreover, greater level
of GSI was associated with problematic sub-
stance use assessed simultaneously with GSI at
T0, T1 and T2 (p < .001), having a lifetime affec-
tive disorder at T0 (p ¼ .007), lifetime anxiety
disorder at T0 (p ¼ .001), and a personality dis-
order at T0 (p < .001). In the adjusted AIC-
reduced model, age was not associated with GSI.
Discussion
The main finding in this study was that in an
adjusted model, problematic substance use
assessed longitudinally, and having lifetime
affective, lifetime anxiety and personality disor-
der at baseline were associated with greater lev-
els of mental distress over the 18-year
observation period. Also, there were significant
differences between females and males in
changes in mental distress from baseline to the
six-year, but not to the 18-year, follow-up.
A clear association between problematic sub-
stance use and greater levels of mental distress is
as expected from epidemiological studies and
reviews (Lai et al., 2015; Regier et al., 1990),
and from longitudinal studies of clinical cohorts
of patients with SUDs followed for up to 10
years (Andreas et al., 2015; Chi & Weisner,
2008). Our finding is important because, to our
knowledge, there are no longitudinal studies
from clinical cohorts of patients with SUDs that
have documented the association between pro-
blematic substance use and greater levels of
mental distress assessed simultaneously for as
long as 18 years. The finding that lifetime affec-
tive, lifetime anxiety and personality disorders
are associated with greater mental distress in














































































































































































































































































































































































































































































































































































































































































































































































































































































































































patients with SUDs is also consistent with other
research and the results from the six-year
follow-up study of the same cohort (Bakken
et al., 2007). Mental distress and psychiatric
diagnoses have some similarities, but differ in
several aspects, and the HSCL-25 and CIDI
diagnoses only partly measure overlapping
dimensions of mental health problems
(Sandanger et al., 1998). We assessed psychia-
tric disorders only at baseline and a positive sig-
nificant association with greater levels of mental
distress suggests that these patients also had
mental disorders over long periods of time. The
results suggest an additive effect between
ongoing problematic substance use, and affec-
tive, anxiety, and personality disorders on
Table 2. Description of levels of mental distress as measured by the HSCL-25 Global Severity Index (GSI) at






n GSI (SD) n GSI (SD) n GSI (SD)
Complete data T0* 232 2.05 (0.58) 130 2.01 (0.63) 72 1.95 (0.59)
Sex
Female 66 2.24 (0.55) 38 1.98 (0.58) 19 2.05 (0.56)
Male 166 1.98 (0.58) 92 2.03 (0.65) 53 1.91 (0.60)
Age (T0)
Under 30 years 60 2.08 (0.59) 30 2.00 (0.61) 19 1.97 (0.68)
30–39 years 72 2.18 (0.59) 43 2.13 (0.63) 25 1.97 (0.53)
40–49 years 56 2.05 (0.57) 34 2.11 (0.62) 19 2.03 (0.58)
50 years and above 44 1.81 (0.58) 23 1.68 (0.60) 9 1.65 (0.54)
Affective disorder lifetime T0
Yes 153 2.20 (0.58) 85 2.11 (0.63) 54 1.98 (0.62)
No 79 1.76 (0.48) 45 1.83 (0.59) 18 1.84 (0.50)
Anxiety disorder lifetime T0
Yes 191 2.13 (0.58) 105 2.11 (0.63) 60 1.97 (0.61)
No 41 1.70 (0.46) 25 1.63 (0.48) 12 1.81 (0.49)
Personality disorder T0
Yes 166 2.18 (0.57) 96 2.10 (0.65) 57 2.03 (0.60)
No 66 1.72 (0.47) 34 1.76 (0.52) 15 1.64 (0.44)
Only AUD (vs poly SUD) T0
Yes 110 1.97 (0.60) 59 1.96 (0.64) 33 1.97 (0.62)
No 122 2.13 (0.56) 71 2.06 (0.62) 39 1.93 (0.57)
Onset of substance use disorder
Onset first SUD before 18 years of age 102 2.09 (0.56) 59 2.16 (0.60) 37 1.94 (0.61)
Onset first SUD after 18 years of age 130 2.02 (0.61) 71 1.89 (0.64) 35 1.95 (0.58)
Problematic substance use**
Yes 232 2.05 (0.58) 89 2.18 (0.57) 34 2.20 (0.57)
No 0 41 1.64 (0.61) 38 1.72 (0.51)
Notes. SUD¼ substance use disorder; AUD¼ alcohol use disorder; HSCL-25¼ The Hopkins Symptom Checklist-25; CIDI
¼ The Composite International Diagnostic Interview; AUDIT ¼ The Alcohol Use Disorders Identification Test; DUDIT ¼
The Drug Use Disorders Identification Test.
*Participants without missing values at HSCL-25 or other assessed covariates at T0.
**All participants had one or several SUDs during the past 12 months at T0 measured with the CIDI, and were defined as
having “problematic substance use” at T0. Participants were divided into those with “current problematic substance use”
(AUDIT > cut-off and/or DUDIT > cut-off during the past 12 months at T1 or T2) and those with “no current problematic
substance use” (AUDIT < cut-off and DUDIT < cut-off during the past 12 months at T1 or T2).
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greater levels of mental distress. This supports
evidence that there is a reciprocal relationship
over time between substance use problems and
mental health problems. It also underlines the
importance of adequate integrated treatment for
both SUDs and mental disorders, because the
long-term prognosis worsens if these comorbid
disorders are left untreated or are poorly treated
(Morisano et al., 2014). In this context, we note
that SUDs and mental health disorders probably
have a shared genetic pre-disposition (Kendler
et al., 2003).
In our results, the substance use factors mea-
sured at baseline, early onset of first SUD and
having only AUD compared with poly-SUDs,
were not associated with greater levels of mental
distress over 18 years and were eliminated from
the adjusted model. By contrast, in the six-year
follow-up study these covariates were predictors
of high mental distress six years later (Bakken
Table 3. The results of linear mixed models assessing associations between the level of mental distress over
the 18 years and patient characteristics associated with change in level of mental distress in time.
Unadjusted modelsa Adjusted modelb
Regr. coeff. (SE) p-value Regr. coeff. (SE) p-value
Intercept

















Problematic substance use at T0, T1 and T2
Affective disorder lifetime at T0
Anxiety disorder lifetime at T0
Personality disorder at T0
Onset first SUD before the age of 18 years






























T1 0.24 (0.11) 0.031 0.22 (0.11) 0.044
T2 0.05 (0.16) 0.735 –0.02 (0.15) 0.908
Notes. SUD ¼ substance use disorder; AUD ¼ alcohol use disorder; HSCL-25 ¼ The Hopkins Symptom Checklist-25.
*Participants with complete data, that is, no missing values at HSCL-25 or other assessed covariates at T0 (n ¼ 232 at T0,
n ¼ 130 at T1, n ¼ 72 at T2). Mental distress is measured by the HSCL-25 Global Severity Index (GSI).
aResults of unadjusted linear mixed models with main effects for time and each pre-defined covariate one covariate at a time.
bResults of the adjusted AIC-reduced linear mixed model, including all covariates and interaction between time and sex.
Figure 2. Illustration of the interaction between
time and sex from the AIC-reduced adjusted linear
mixed model, presented in Table 3.
Notes. AIC ¼ Akaike’s Information Criterion. The y-axis
shows mental distress measured with the Global Severity
Index (GSI) of The Hopkins Symptom Checklist-25. The x-
axis shows time in years: 0 years (T0), 6 years (T1) and 18
years (T2). The error bars at 0 years (T0), 6 years (T1) and
18 years (T2) are 95% confidence intervals.
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et al., 2007). This negative result for baseline
substance use factors may be related to the char-
acteristics of the cohort, as baseline differences
were observed between participants with only
AUD and those with poly-SUDs. Although the
cohort was heterogeneous in the sense of includ-
ing females and males, a wide range of ages and
different SUDs, on average the patients had
severe and long-lasting SUDs. This may have
made it difficult to detect potential differences
in substance use factors.
Several studies have shown that females in
treatment for SUDs have higher psychiatric
comorbidity than males, particularly for mood
and anxiety disorders (Brady & Randall, 1999;
Landheim et al., 2003; Zilberman et al., 2003).
According to descriptive statistics in the present
study we can see that females on average scored
somewhat higher than males on mental distress
at both baseline and at the 18-year follow-up.
Perhaps more interestingly, when exploring the
interaction between sex and time in the adjusted
model, we found a difference between females
and males in the change in mental distress from
baseline to the six-year, but not to the 18-year
follow-up. These results over 18 years do not
support the notion raised after the six-year
follow-up study, that mental distress is more
strongly associated with ongoing problematic
substance use in females than in males (Bakken
et al., 2007). There were relatively few females
in the study, especially at the follow-ups, and
thus these findings on sex differences should be
interpreted with caution.
Limitations
Our study is vulnerable to selection bias (Sack-
ett, 1979) because the participants have a rela-
tively high mean age, and both long-lasting
SUDs and high comorbidity with mental disor-
ders at baseline. Younger patients with both bet-
ter and worse prognoses may have been
underrepresented. A substantial decrease in the
number of participants over time because of
mortality and non-participation is inevitable in
such a cohort, and may have led to attrition bias
(Deeg, 2002). Some differences in characteris-
tics were seen between surviving participants
and deceased participants during the observation
time, but no differences were found between
participants with complete data and those with
missing values at baseline. This non-random
loss of participants over time is also a problem
when applying linear mixed models. However,
the joint modelling of longitudinal outcome and
death, clearly indicated that death could be
treated as non-informative, and that it did not
bias the results in any substantial way. Having
more than three measuring points during the 18
years would have provided more detailed infor-
mation about the development of mental distress
over time. There can also be problems in mea-
suring mental disorders at baseline in relative
temporal proximity to substance abuse, and the
diagnoses can differ between those reached via
structured diagnostic interviews, as used in the
present study, compared with those reached by
clinical experts, who likely set fewer diagnoses
(Andrews & Peters, 1998). All data at the time of
the six- and 18-year follow-up measurements
were self-reported, and self-reported data can
be prone to recall bias (Coughlin, 1990) and
skewed self-presentation (Mortel, 2008), which
may lead to both under and overreporting.
The main strengths of this study were the 18-
year period, the heterogeneous clinical cohort
with long-term problematic substance use, and
the thorough diagnostic investigation with struc-
tured personal interviews at baseline. Despite
limitations, this study provides unique docu-
mentation of the long-term levels of mental dis-
tress and its association with long-term
problematic substance use, and mental disorders
in patients with SUDs.
Conclusion
The results suggest a reciprocal relationship
over time between substance use and mental
health problems. Also, there seems to be an
additive effect between ongoing problematic
substance use and lifetime mental disorders on
greater levels of mental distress. This addresses
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the importance of integrated treatment for both
substance use disorders and mental disorders to
improve the long-term course for patients with
these comorbid disorders.
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